Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2026-01-06 @ 7:14 AM
Study NCT ID:
NCT00244257
Status:
TERMINATED
Last Update Posted:
2015-04-09
First Post:
2005-10-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)
Sponsor:
Genzyme, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-08
Start Date Type:
None
Primary Completion Date:
2008-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-07
Completion Date Type:
ACTUAL
First Submit Date:
2005-10-25
First Submit QC Date:
None
Study First Post Date:
2005-10-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-04-08
Last Update Post Date:
2015-04-09
Last Update Post Date Type:
ESTIMATED